Subsequently, many different GLP-1R agonists were developed and approved, including : extended release exenatide (exenatide XR), liraglutide, lixisenatide , dulaglutide , and semaglutide (Table 1)
Retatrutide should not be considered a replacement for established psychiatric treatment
Research in this area typically focuses on intestinal growth, mucosal integrity, and nutrient absorption
In other words, subjects will likely need a higher dose of intranasal spray to achieve comparable results to injections
However, these charts offer general guidance only and cannot replace personalised medical review
In the face of high discontinuation rates and policy-imposed treatment duration limits, our findings underscore the need for an urgent re-evaluation of prescribing guidelines